Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

View source ↗

Summary

A clinical trial is investigating optimized diagnostic approaches for Pneumocystis pneumonia in immunocompromised patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pneumocystis, Immunocompromised Patients | Status: RECRUITING